Supplementary Online Content

Size: px
Start display at page:

Download "Supplementary Online Content"

Transcription

1 Supplementary Online Content Viktorin A, Uher R, Kolevzon A, Reichenberg A, Levine SZ, Sandin S. Association of antidepressant medication use during pregnancy with intellectual disability in offspring. JAMA Psychiatry. Published online July 12, doi: /jamapsychiatry etable 1. List of Medications Considered in the Study etable 2. Psychotropic Drugs During Pregnancy etable 3. Detailed Information About Parental Education Levels etable 4. Psychiatric Diagnosis Codes Included in the Study etable 5. Clinical Subsample Subject Characteristics efigure 1. Medication Exposure Definition efigure 2. Kaplan-Meier Failure Estimate of Intellectual Disability efigure 3. Relative Risks of Intellectual Disability in Children of Mothers With a Single Dispensation of Any Antidepressant During Pregnancy efigure 4. Relative Risks of Intellectual Disability in Children of Mothers With Any Number of Dispensations of Any Type Antidepressant During Pregnancy efigure 5. Plotted Schoenfeldt Residuals for Each Covariate With 4 Degrees of Freedom efigure 6. Relative Risks of Mild to Moderate Intellectual Disability efigure 7. Relative Risks of Severe Intellectual Disability efigure 8. Relative Risks of Intellectual Disability Without Comorbid Autism Spectrum Disorder efigure 9. Results From Bootstrapped Analyses efigure 10. Sex-Specific and Sex-Combined Relative Risks of Intellectual Disability efigure 11. Relative Risks of Intellectual Disability in Children of Mothers Treated With Antidepressants During Pregnancy, Including Gestational Age and Birth Weight efigure 12. Trimester-Specific Relative Risks of Intellectual Disability efigure 13. Duration-Dose-Response Effect on the Relative Risk of Intellectual Disability efigure 14. Effects of Potential Misclassification in Unexposed Children efigure 15. Relative Risks of Intellectual Disability Stratified on Maternal Polypharmacy efigure 16. Percentage of Mothers With Medication During Pregnancy and a Psychiatric Diagnosis Before Child Birth efigure 17. Relative risks of Intellectual Disability Due to Exposure to Any Antidepressant During Pregnancy, Where All Antidepressant Treated Mothers Were Assumed to Have Depression This supplementary material has been provided by the authors to give readers additional information about their work.

2 etable 1. List of Medications Considered in the Study* Abbreviations: ATC, Anatomical Therapeutic Chemical Classification System. * List of medications with drug names and ATC codes considered in the study.

3 etable 2. Psychotropic Drugs During Pregnancy* Abbreviations: ATC, Anatomical Therapeutic Chemical Classification System. * The sample consists of the mothers with at least two dispensations overlapping pregnancy with either antidepressants (N=3,982) or other psychotropic drugs (N=1,626). The table presents the number of mothers with at least one dispensation overlapping pregnancy with the specific psychotropic drugs considered in the study (see etable 1). Any drug listed in etable 1 not in this table list was not observed in the sample.

4 etable 3. Detailed Information About Parental Education Levels Full Population sample Antidepressant medication during pregnancy Characteristics, N (%) Unexposed a Exposed b Uncertain c Maternal education level Compulsory school shorter than 9 years 8,179 (4.7) 107 (2.7) 73 (3.1) Compulsory school 9 years 13,587 (7.9) 620 (15.6) 382 (16.1) Upper secondary school up to 2 years 19,079 (11.1) 673 (16.9) 387 (16.3) Upper secondary school 3 years 49,860 (28.9) 1,119 (28.1) 671 (28.2) Post-secondary education less than 3 years 21,037 (12.2) 486 (12.2) 301 (12.7) University 3 years 59,315 (34.4) 952 (23.9) 552 (23.2) Doctoral education 1,589 (0.9) 25 (0.6) 13 (0.6) Paternal education level Compulsory school shorter than 9 years 7,732 (4.5) 123 (3.1) 103 (4.3) Compulsory school 9 years 16,333 (9.5) 506 (12.7) 282 (11.9) Upper secondary school up to 2 years 35,168 (20.4) 1, (24.5) (25.4) Upper secondary school 3 years 46,771 (27.1) 1, (28.6) (27.7) Post-secondary education less than 3 years 24,063 (13.9) 500 (12.6) 280 (11.8) University 3 years 40,007 (23.2) 706 (17.7) 431 (18.1) Doctoral education 2,572 (1.5) 33 (0.8) 21 (0.9) Abbreviations: N, Number. SD, standard deviation. NA, Not applicable. a Children of mothers with no antidepressant dispensation with a medication period overlapping pregnancy. b Children of mothers with at least two antidepressant dispensations with medication periods overlapping pregnancy (efigure 1 example A1 and example A2). c Children of mothers with a single antidepressant dispensation with a medication period overlapping pregnancy.

5 etable 4. Psychiatric Diagnosis Codes included in the Study* Abbreviations: ICD, International Classification of Diseases. ADHD, attention deficit hyperactivity disorder. ASD, autism spectrum disorder. NA, not available. *Note: * at the end of a diagnosis code indicates all sub-categories.

6 etable 5. Clinical Subsample Subject Characteristics Clinical sub-sample a Antidepressant medication during pregnancy Characteristics, No (%) Unexposed b Exposed c Uncertain d Number of offspring 4,976 (62.0) 2,372 (29.6) 673 (8.4) Offspring with intellectual disability 36 (0.7) 27 (1.1) 6 (0.9) Offspring with severe intellectual disability 5 (0.1) 3 (0.1) 0 (0.0) Offspring with intellectual disability without 28 (0.6) 18 (0.8) 6 (0.9) autism spectrum disorder Maternal use of psychotropic medication other 229 (4.6) 448 (18.9) 71 (10.6) than antidepressants during pregnancy Paternal psychotropic medication during 348 (7.0) 286 (12.1) 64 (9.5) pregnancy Birth year ,912 (38.4) 937 (39.5) 254 (37.7) ,064 (61.6) 1,435 (60.5) 419 (62.3) Maternal psychiatric diagnosis 4,976 (100) 2,372 (100) 673 (100) Paternal psychiatric diagnosis 1,192 (24.0) 590 (24.9) 167 (24.8) Maternal age (years) at delivery < (3.3) 45 (1.9) 34 (5.1) ,460 (49.4) 1,013 (42.7) 310 (46.1) ,182 (43.9) 1,190 (50.2) 304 (45.2) (3.4) 124 (5.2) 25 (3.7) Paternal age (years) at delivery <20 53 (1.1) 14 (0.6) 8 (1.2) ,820 (36.6) 765 (32.3) 254 (37.7) ,391 (48.1) 1,207 (50.9) 334 (49.6) (14.3) 386 (16.3) 77 (11.4) Maternal education above 9 years 3,703 (74.4) 1,846 (77.8) 499 (74.2) Paternal education above 9 years 3,950 (79.4) 1,961 (82.7) 540 (80.2) Offspring sex Males 2,552 (51.3) 1,216 (51.3) 334 (49.6) Females 2,424 (48.7) 1,156 (48.7) 339 (50.4) Gestational age in days, mean (SD) (15.0) (15.7) (14.4) Exposure duration, mean (SD) Days NA (76.4) 54.5 (32.1) Percentage of pregnancy length NA 60.2 (28.1) 19.8 (11.7) Exposure during trimesters, N (%) First trimester NA 2,223 (93.7) 585 (86.9) Second trimester NA 2,041 (86.1) 246 (36.6) Third trimester NA 1,507 (63.5) 114 (16.9) Abbreviations: No, number of children. SD, standard deviation. NA, not applicable. a A clinically relevant sub-sample consisting of 8,021 children, of which 69 had been diagnosed with intellectual disability. All mothers, both medicated and non-medicated, had at least one diagnosis of depression or an anxiety disorder prior child birth (etable 4). Thereby, the offspring of mothers with medication during pregnancy is contrasted with offspring of mothers that may share similar underlying factors. b Children of mothers with no antidepressant dispensation with a medication period overlapping pregnancy.

7 c Children of mothers with at least two antidepressant dispensations with medication periods overlapping pregnancy (efigure 1 example A1 and example A2). d Children of mothers with a single antidepressant dispensation with a medication period overlapping pregnancy. e Details of mothers and fathers education within 7 levels is provided in Supplement etable 3.

8 efigure 1. Medication Exposure Definition* Abbreviations: Disp., dispensation. * Exposure to medication during pregnancy was established in both parents using dispensation dates, number of pills dispensed, and the DDD - the assumed average maintenance dose per day for a drug used for its main indication in adults, provided by the World Health Organization (WHO). For antidepressants, medication was assumed to cover the time from the dispensation date until an end date based on number of pills dispensed, assuming one pill was consumed per day. For any other psychotropic drug, the medication period was calculated based on the dispensation dates and the number of pills dispensed divided by the medication-specific DDD. To be classified as using a medication during pregnancy, a continuous pattern of dispensations was required according to either a) at least two dispensations during pregnancy (example A in Figure), or b) a single dispensation (one-time dispensation) during pregnancy, and a second previous dispensation covering the pregnancy (example B in Figure). However, offspring to mothers with a one-time dispensation was not included in the main results but analyzed and presented separately (N=2,370; efigure 3), and in combination with mothers having at least two dispensations with medication periods in pregnancy (N=6,361; efigure 4).

9 0.0 % 0.5% Prevalence efigure 2. Kaplan-Meier Failure Estimate of Intellectual Disability* Kaplan-Meier failure estimate Analysis time (years) * Plotted Kaplan-Meier failure estimate of intellectual disability in the children of the cohort, showing a gradual increase in number of children receiving their first diagnosis of intellectual disability over follow-up. The children are followed from birth in 2006 and 2007 and throughout 2014 when aged 7 to 8.

10 efigure 3. Relative Risks of Intellectual Disability in Children of Mothers With a Single Dispensation of Any Antidepressant During Pregnancy* Abbreviations: N, number of children. CI, confidence interval. * The full sample consists of 179,007 children born during 2006 and 2007, of which 873 had been diagnosed with intellectual disability, and 3,982 had were born to a mother with antidepressant treatment during pregnancy. The figure presents relative risks of intellectual disability and twosided 95% confidence intervals in children of mothers with a single dispensation of an antidepressant drug overlapping the pregnancy (N=2,379), compared with unexposed children. a A clinically relevant sub-sample consisting of 8,021 children, of which 69 had been diagnosed with intellectual disability, and 2,372 had were born to a mother with antidepressant treatment during pregnancy. All mothers, both medicated and non-medicated, had at least one diagnosis of depression or an anxiety disorder prior child birth (etable 4). Thereby, the offspring of mothers with medication during pregnancy is contrasted with offspring of mothers that may share similar underlying factors. b Analyses not adjusted for covariates. c Analyses adjusted for birthdate, maternal and paternal age, the father's psychotropic medication overlapping the pregnancy, and maternal and paternal education level at child birth. d Analyses adjusted for the factors listed in c, and for any maternal diagnoses of depression prior child birth (yes/no) (see etable 4 for specific diagnosis codes). e Analyses adjusted for the factors listed in c, and for maternal and paternal diagnoses prior child birth of specific psychiatric disorder subgroups in either the mother and/or father's life time (yes/no), including depression, anxiety disorders, substance use disorder, bipolar disorder, compulsive disorder, attention deficit hyperactive disorder (ADHD), autism spectrum disorder, intellectual disability, schizophrenia, and 'other psychiatric diagnosis' (see etable 4 for specific diagnosis codes).

11 efigure 4. Relative Risks of Intellectual Disability in Children of Mothers With Any Number of Dispensations of Any Type Antidepressant During Pregnancy* Abbreviations: N, number of children. CI, confidence interval. * The full sample consists of 179,007 children born during 2006 and 2007, of which 873 had been diagnosed with intellectual disability, and 3,982 had were born to a mother with antidepressant treatment during pregnancy. The figure presents relative risks of intellectual disability and twosided 95% confidence intervals in children of mothers with any number of dispensations of an antidepressant drug overlapping the pregnancy (N=6,361), compared with unexposed children. a A clinically relevant sub-sample consisting of 8,021 children, of which 69 had been diagnosed with intellectual disability, and 3,045 had were born to a mother with any number of antidepressant dispensations during pregnancy. All mothers, both medicated and non-medicated, had at least one diagnosis of depression or an anxiety disorder prior child birth (etable 4). Thereby, the offspring of mothers with medication during pregnancy is contrasted with offspring of mothers that may share similar underlying factors. b Analyses not adjusted for covariates. c Analyses adjusted for birthdate, maternal and paternal age, the father's psychotropic medication overlapping the pregnancy, and maternal and paternal education level at child birth. d Analyses adjusted for the factors listed in c, and for any maternal diagnoses of depression prior child birth (yes/no) (see etable 4 for specific diagnosis codes). e Analyses adjusted for the factors listed in c, and for maternal and paternal diagnoses prior child birth of specific psychiatric disorder subgroups in either the mother and/or father's life time (yes/no), including depression, anxiety disorders, substance use disorder, bipolar disorder, compulsive disorder, attention deficit hyperactive disorder (ADHD), autism spectrum disorder, intellectual disability, schizophrenia, and 'other psychiatric diagnosis' (see etable 4 for specific diagnosis codes).

12 efigure 5. Plotted Schoenfeldt Residuals for Each Covariate With 4 Degrees of Freedom

13

14

15

16

17 efigure 6. Relative Risks of Mild to Moderate Intellectual Disability* Abbreviations: N, number of births to treated mothers. SSRI, selective serotonin re-uptake inhibitor. CI, confidence interval. * Relative risks of mild to moderate intellectual disability and two-sided 95% confidence intervals in children to mothers with antidepressant or other psychotropic medication during pregnancy compared with children to mothers without any psychotropic medication during pregnancy. The sample consists of 179,007 children born during 2006 and 2007, of which 767 had been diagnosed with mild to moderate intellectual disability. a Analyses not adjusted for covariates. b Analyses adjusted for birthdate, maternal and paternal age, the father's psychotropic medication overlapping the pregnancy, and maternal and paternal education level at child birth. c Analyses adjusted for the factors listed in d, and for any maternal diagnosis of depression prior child birth (yes/no) (see etable 4 for specific diagnosis codes). d Analyses adjusted for the factors listed in d, and maternal and paternal diagnoses prior child birth of specific mental illness subgroups (yes/no), including depression, anxiety disorders, substance use disorder, bipolar disorder, compulsive disorder, attention deficit hyperactive disorder (ADHD), autism spectrum disorder, intellectual disability, schizophrenia, and 'other psychiatric diagnosis' (see etable 4 for specific diagnosis codes).

18 efigure 7. Relative Risks of Severe Intellectual Disability* Abbreviations: N, number of births to treated mothers. SSRI, selective serotonin re-uptake inhibitor. CI, confidence interval. * Relative risks of severe intellectual disability and two-sided 95% confidence intervals in children to mothers with antidepressant or other psychotropic medication during pregnancy compared with children to mothers without any psychotropic medication during pregnancy. The sample consists of 179,007 children born during 2006 and 2007, of which 106 had been diagnosed with severe intellectual disability. a Analyses not adjusted for covariates. b Analyses adjusted for birthdate, maternal and paternal age, the father's psychotropic medication overlapping the pregnancy, and maternal and paternal education level at child birth. c Analyses adjusted for the factors listed in d, and for any maternal diagnosis of depression prior child birth (yes/no) (see etable 4 for specific diagnosis codes). d Analyses adjusted for the factors listed in d, and maternal and paternal diagnoses prior child birth of specific mental illness subgroups (yes/no), including depression, anxiety disorders, substance use disorder, bipolar disorder, compulsive disorder, attention deficit hyperactive disorder (ADHD), autism spectrum disorder, intellectual disability, schizophrenia, and 'other psychiatric diagnosis' (see etable 4 for specific diagnosis codes).

19 efigure 8. Relative Risks of Intellectual Disability Without Comorbid Autism Spectrum Disorder* Abbreviations: N, number of births to treated mothers. SSRI, selective serotonin re-uptake inhibitor. CI, confidence interval. * Relative risks of intellectual disability without comorbid autism spectrum disorder and two-sided 95% confidence intervals in children to mothers with antidepressant or other psychotropic medication during pregnancy compared with children to mothers without any psychotropic medication during pregnancy. The sample consists of 179,007 children born during 2006 and 2007, of which 513 had been diagnosed with intellectual disability without comorbid autism spectrum disorder. a Analyses not adjusted for covariates. b Analyses adjusted for birthdate, maternal and paternal age, the father's psychotropic medication overlapping the pregnancy, and maternal and paternal education level at child birth. c Analyses adjusted for the factors listed in d, and for any maternal diagnosis of depression prior child birth (yes/no) (see etable 4 for specific diagnosis codes). d Analyses adjusted for the factors listed in d, and maternal and paternal diagnoses prior child birth of specific mental illness subgroups (yes/no), including depression, anxiety disorders, substance use disorder, bipolar disorder, compulsive disorder, attention deficit hyperactive disorder (ADHD), autism spectrum disorder, intellectual disability, schizophrenia, and 'other psychiatric diagnosis' (see etable 4 for specific diagnosis codes).

20 efigure 9. Results From Bootstrapped Analyses* Abbreviations: N, number of births to treated mothers. SSRI, selective serotonin re-uptake inhibitor. CI, confidence interval. * Relative risks of intellectual disability and two-sided 95% confidence intervals in children to mothers with antidepressant or other psychotropic medication during pregnancy compared with children to mothers without any psychotropic medication during pregnancy. The sample consists of 179,007 children born during 2006 and 2007, of which 873 had been diagnosed with intellectual disability without comorbid autism spectrum disorder. Bootstrapping was performed with 100 repetitions. a Mothers not using antidepressant, but other psychotropic medication during pregnancy. b Relative risk and 95% CI for 1) any antidepressant (top in black), 2) SSRI antidepressants (2 nd in red), 3) other antidepressants (3 rd in green), and 4) other psychotropic drugs (bottom in yellow), repeated for each level of adjustment. c Analyses not adjusted for covariates. d Analyses adjusted for birthdate, maternal and paternal age, the father's psychotropic medication overlapping the pregnancy, and maternal and paternal education level at child birth. e Analyses adjusted for the factors listed in d, and any maternal diagnosis of depression prior child birth (yes/no) (see etable 4 for specific diagnosis codes). f Analyses adjusted for the factors listed in d, and maternal and paternal diagnoses prior child birth of specific mental illness subgroups (yes/no), including depression, anxiety disorders, substance use disorder, bipolar disorder, compulsive disorder, attention deficit hyperactive disorder (ADHD), autism spectrum disorder, intellectual disability, schizophrenia, and 'other psychiatric diagnosis' (see etable 4 for specific diagnosis codes).

21 efigure 10. Sex-Specific an Sex-Combined Relative Risks of Intellectual Disability* Abbreviations: N, number of births to treated mothers. RR, relative risk. CI, confidence interval. * Sex-combined and sex-specific relative risks of intellectual disability and two-sided 95% confidence intervals in children to mothers with antidepressant medication during pregnancy compared with children to mothers without any psychotropic medication during pregnancy. The sample consists of 179,007 children born during 2006 and 2007, of which 90,090 (51.5%) were males and 84,935 (48.5%) females. There were 873 children diagnosed with intellectual disability, of which 545 (62.4% of cases; 0.3% of all children) where male, and 328 (37.6% of cases; 0.2% of all children) female. a Analyses not adjusted for covariates. b Analyses adjusted for birthdate, maternal and paternal age, the father's psychotropic medication overlapping the pregnancy, and maternal and paternal education level at child birth. c Analyses adjusted for the factors listed in c, and for any maternal diagnosis of depression prior childbirth (yes/no) (see etable 4 for specific diagnosis codes). d Analyses adjusted for the factors listed in c, and for maternal or paternal diagnoses prior child birth of specific psychiatric disorder subgroups (yes/no), including depression, anxiety disorders, substance use disorder, bipolar disorder, compulsive disorder, attention deficit hyperactive disorder (ADHD), autism spectrum disorder, intellectual disability, schizophrenia, and 'other psychiatric diagnosis' (see etable 4 for specific diagnosis codes).

22 efigure 11. Relative Risks of Intellectual Disability in Children of Mothers Treated With Antidepressants During Pregnancy, Including Gestational Age and Birth Weight * Abbreviations: RR, relative risk. CI, confidence interval. * Relative risks of intellectual disability and two-sided 95% confidence intervals in children to mothers with antidepressant medication during pregnancy compared with children to mothers without antidepressant medication during pregnancy. The analyses examine the role of gestational age and birth weight in the causal pathway. a Results from Model 4 in Figure 1. b Model 4 in Figure 1, with additional adjustment for gestational age in days (RR: 0.98; 95% CI ; p-value < 0.001). All children had gestational age information. c Model 4 in Figure 1, with additional adjustment for birth weight in grams (RR: 1.00; 95% CI ; p-value < 0.001). There were 271 children without birth weight information. In these children, we used the cohort mean birth weight stratified on offspring sex. d Model 4 in Figure 1, with additional adjustment for gestational age in days and birth weight in grams. Gestational age and birth weight were closely correlated in the cohort (Pearson s correlation coefficient 0.66; p-value <0.0001). e Model 4 in Figure 1, confined to children with term birth (born after 259 days of gestation). f Model 4 in Figure 1, confined to children with a birthweight above 3000 grams.

23 efigure 12. Trimester-Specific Relative Risks of Intellectual Disability* Abbreviations: N, number of children. CI, confidence interval. RR, relative risk. * Analyses of the association between antidepressant exposure at specific trimesters and intellectual disability in the offspring. The analyses allowed exposure in several trimesters, and correspond to Model 4 in the main analysis (Figure 1), adjusting for all included covariates.

24 efigure 13. Duration-Dose-Response Effect on the Relative Risk of Intellectual Disability* Abbreviations: N, number of children. CI, confidence interval. RR, relative risk. * The full sample consists of 179,007 children born during 2006 and 2007, of which 873 had been diagnosed with intellectual disability, and 3,982 had were born to a mother with antidepressant treatment during pregnancy. The figure presents relative risks of intellectual disability and twosided 95% confidence intervals in children of mothers with at least two dispensations of antidepressant drugs overlapping the pregnancy, compared with unexposed children. a A clinically relevant sub-sample consisting of 8,021 children, of which 69 had been diagnosed with intellectual disability, and 2,372 had were born to a mother with antidepressant treatment during pregnancy. All mothers, both medicated and non-medicated, had at least one diagnosis of depression or an anxiety disorder prior child birth (etable 4). Thereby, the offspring of mothers with medication during pregnancy is contrasted with offspring of mothers that may share similar underlying factors. b Analyses adjusted for the mean difference of antidepressant exposure duration from the mean, separately in the exposed and unexposed children. This was done by creating an additional covariate that reflect the deviation from the mean number of days with antidepressant treatment during pregnancy. Thus, in exposed children, the mean number of days exposed to antidepressants was estimated at 156 (Table 1), which was set to 0. Children with fewer days of antidepressant exposure during pregnancy than 156 would get a negative number reflecting the difference in duration from the mean, and vice versa for children with longer duration. All children unexposed to maternal antidepressant treatment during pregnancy would have the value 0. For each additional 30 days (approximately a month) of exposure longer than the mean duration of exposure (156 days), the RR was estimated at 1.01 (95% CI: ; P-value: 0.88). c Analyses adjusted for duration of medication exposure (explained in b ), birthdate, maternal and paternal age, the father's psychotropic medication overlapping the pregnancy, and maternal and paternal education level at child birth. d Analyses adjusted for the factors listed in c, and for any maternal diagnosis of depression prior childbirth (yes/no) (see etable 4 for specific diagnosis codes). e Analyses adjusted for the factors listed in c, and for maternal or paternal diagnoses prior child birth of specific psychiatric disorder subgroups (yes/no), including depression, anxiety disorders, substance use disorder, bipolar disorder, compulsive disorder, attention deficit hyperactive disorder (ADHD), autism spectrum disorder, intellectual disability, schizophrenia, and 'other psychiatric diagnosis' (see etable 4 for specific diagnosis codes).

25 efigure 14. Effects of Potential Misclassification in Unexposed Children* Abbreviations: N, number of children. RR, relative risk. CI, confidence interval. * To estimate the potential effect of misclassification in children born to mothers without antidepressant medication in pregnancy, but that may have medication prior conception, the sample was restricted to children conceived after January , to allow six months follow-up prior conception (the Swedish Prescribed Drug Register began follow-up at July ). The full sample consists of 125,257 children, of which 598 had been diagnosed with intellectual disability, and 2,949 were born to a mother with antidepressant treatment during pregnancy. Antidepressant unexposed children had to be born to a mother without any antidepressant medication in pregnancy, however, medication in the six months prior conception was not considered. In a second sample of 123,964 children, antidepressant medication in the six months prior conception was considered and any children defined as unexposed had to be born to a mother with neither antidepressant medication during pregnancy, nor in the six months preceding pregnancy. This excluded 1,293 children. a Analyses not adjusted for covariates. b Analyses adjusted for birthdate, maternal and paternal age, the father's psychotropic medication overlapping the pregnancy, and maternal and paternal education level at child birth. c Analyses adjusted for the factors listed in c, and for any maternal diagnosis of depression prior childbirth (yes/no) (see etable 4 for specific diagnosis codes). d Analyses adjusted for the factors listed in c, and for maternal or paternal diagnoses prior child birth of specific psychiatric disorder subgroups (yes/no), including depression, anxiety disorders, substance use disorder, bipolar disorder, compulsive disorder, attention deficit hyperactive disorder (ADHD), autism spectrum disorder, intellectual disability, schizophrenia, and 'other psychiatric diagnosis' (see etable 4 for specific diagnosis codes).

26 efigure 15. Relative Risks of Intellectual Disability Stratified on Maternal Polypharmacy* Abbreviations: N, number of children. RR, relative risk. CI, confidence interval. * The full sample consists of 179,007 children born during 2006 and 2007, of which 873 had been diagnosed with intellectual disability, and 3,982 had were born to a mother with antidepressant treatment during pregnancy. The figure presents relative risks of intellectual disability and twosided 95% confidence intervals in analyses stratified on maternal polypharmacy, defined as having any dispensation with a non-antidepressant psychotropic medication with a medication period overlapping pregnancy. There were 3,059 children of mothers without any dispensation of a nonantidepressant psychotropic medication in pregnancy, and 923 children of mothers with at least one dispensation with a non-antidepressant psychotropic medication with a medication period overlapping pregnancy. a Analyses not adjusted for covariates. b Analyses adjusted for birthdate, maternal and paternal age, the father's psychotropic medication overlapping the pregnancy, and maternal and paternal education level at child birth. c Analyses adjusted for the factors listed in c, and for any maternal diagnosis of depression prior childbirth (yes/no) (see etable 4 for specific diagnosis codes). d Analyses adjusted for the factors listed in c, and for maternal or paternal diagnoses prior child birth of specific psychiatric disorder subgroups (yes/no), including depression, anxiety disorders, substance use disorder, bipolar disorder, compulsive disorder, attention deficit hyperactive disorder (ADHD), autism spectrum disorder, intellectual disability, schizophrenia, and 'other psychiatric diagnosis' (see etable 4 for specific diagnosis codes).

27 efigure 16. Percentage of Mothers With Medication During Pregnancy and a Psychiatric Diagnosis Before Child Birth* Abbreviations: SSRI, selective serotonin re-uptake inhibitor. ADHD, attention-deficit hyperactive disorder. ASD, autism spectrum disorder. * Mothers with medication during pregnancy (at least two dispensations with medication periods overlapping pregnancy, see efigure 1; N=5,608) with either SSRI antidepressants (N=3,178), non- SSRI antidepressants (N=804), or non-antidepressant psychotropic medications (N=1,626), and the percentage of these mothers having a diagnosis in the Swedish Patient Register.

28 efigure 17. Relative Risks of Intellectual Disability Due to Exposure to Any Antidepressant During Pregnancy, Where All Antidepressant Treated Mothers Were Assumed to Have Depression* Abbreviations: N, number of children. CI, confidence interval. RR, relative risk. * The full sample consists of 179,007 children born during 2006 and 2007, of which 873 had been diagnosed with intellectual disability, and 3,982 had were born to a mother with antidepressant treatment during pregnancy. The figure presents relative risks of intellectual disability and twosided 95% confidence intervals in children of mothers with at least two dispensations of antidepressant drugs overlapping the pregnancy, compared with unexposed children. Among mothers with antidepressant medication during pregnancy, 25% lack any psychiatric diagnosis in the Swedish Patient Register. The Swedish Patient Register lack primary care information, and antidepressant medication is accompanied with a diagnosis in the Swedish healthcare system. Therefore, it is possible that the lack of a psychiatric diagnosis in 25% of the mothers with antidepressant medication cause residual confounding. In an attempt to estimate the size of the potential residual confounding by lack of psychiatric diagnosis from the primary care, in this analysis, all mothers with antidepressant medication was also assumed having suffered depression. Model 3 and Model 4 in the full sample shows the estimated relative risks if all antidepressant treated mothers were also assumed having suffered depression. a A clinically relevant sub-sample consisting of 8,021 children, of which 69 had been diagnosed with intellectual disability, and 2,372 had were born to a mother with antidepressant treatment during pregnancy. All mothers, both medicated and non-medicated, had at least one diagnosis of depression or an anxiety disorder prior child birth (etable 4). Thereby, the offspring of mothers with medication during pregnancy is contrasted with offspring of mothers that may share similar underlying factors. b Analyses not adjusted for covariates. c Analyses adjusted for birthdate, maternal and paternal age, the father's psychotropic medication overlapping the pregnancy, and maternal and paternal education level at child birth. d Analyses adjusted for the factors listed in c, and for any maternal diagnosis of depression prior child birth (yes/no) (see etable 4 for specific diagnosis codes). e Analyses adjusted for the factors listed in c, and for maternal and paternal diagnoses prior child birth of specific psychiatric disorder subgroups (yes/no), including depression, anxiety disorders, substance use disorder, bipolar disorder, compulsive disorder, attention deficit hyperactive disorder (ADHD), autism spectrum disorder, intellectual disability, schizophrenia, and 'other psychiatric diagnosis' (see etable 4 for specific diagnosis codes).

Paternal use of antidepressants and offspring outcomes in Sweden: nationwide prospective cohort study

Paternal use of antidepressants and offspring outcomes in Sweden: nationwide prospective cohort study Paternal use of antidepressants and offspring outcomes in Sweden: nationwide prospective cohort study Alexander Viktorin, 1 Stephen Z Levine, 2 Margret Altemus, 3 Abraham Reichenberg, 4,5 Sven Sandin 1,4,5

More information

Author Appendix Contents. Appendix A. Model fitting results for Autism and ADHD by 8 years old

Author Appendix Contents. Appendix A. Model fitting results for Autism and ADHD by 8 years old 1 Author Appendix Contents Appendix A. Model fitting results for Autism and ADHD by 8 years old Appendix B. Results for models controlling for paternal age at first childbearing while estimating associations

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Huybrechts KF, Hernández-Díaz S, Patorno E, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry. Published online August 17, 2016.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Sandin S, Nygren K-G, Iliadou A, Hultman C, Reichenberg. Autism and Mental Retardation Among Offspring Born After In Vitro Fertilization. JAMA. doi:10.1001/jama.2013.7222.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Mok PLH, Pedersen CB, Springate D, et al. Parental psychiatric disease and risks of attempted suicide and violent criminal offending in offspring: a population-based cohort

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lu Y, Sjölander A, Cederlöf M, et al. Association between medication use and performance on higher education entrance tests in individuals with attentiondeficit/hyperactivity

More information

Supplementary Methods

Supplementary Methods Supplementary Materials for Suicidal Behavior During Lithium and Valproate Medication: A Withinindividual Eight Year Prospective Study of 50,000 Patients With Bipolar Disorder Supplementary Methods We

More information

Challenges in design and analysis of large register-based epidemiological studies

Challenges in design and analysis of large register-based epidemiological studies FMS/DSBS autumn meeting 2014 Challenges in design and analysis of large register-based epidemiological studies Caroline Weibull & Anna Johansson Department of Medical Epidemiology and Biostatistics (MEB)

More information

S P O U S A L R ES E M B L A N C E I N PSYCHOPATHOLOGY: A C O M PA R I SO N O F PA R E N T S O F C H I LD R E N W I T H A N D WITHOUT PSYCHOPATHOLOGY

S P O U S A L R ES E M B L A N C E I N PSYCHOPATHOLOGY: A C O M PA R I SO N O F PA R E N T S O F C H I LD R E N W I T H A N D WITHOUT PSYCHOPATHOLOGY Aggregation of psychopathology in a clinical sample of children and their parents S P O U S A L R ES E M B L A N C E I N PSYCHOPATHOLOGY: A C O M PA R I SO N O F PA R E N T S O F C H I LD R E N W I T H

More information

Mental Health Series for Perinatal Prescribers. Pharmacotherapy for depression and anxiety

Mental Health Series for Perinatal Prescribers. Pharmacotherapy for depression and anxiety Mental Health Series for Perinatal Prescribers Pharmacotherapy for depression and anxiety Non-medication Treatments Psychosocial support Prenatal education, Doula support, La Leche League, Mom s groups,

More information

Aggregation of psychopathology in a clinical sample of children and their parents

Aggregation of psychopathology in a clinical sample of children and their parents Aggregation of psychopathology in a clinical sample of children and their parents PA R E N T S O F C H I LD R E N W I T H PSYC H O PAT H O LO G Y : PSYC H I AT R I C P R O B LEMS A N D T H E A S SO C I

More information

Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study

Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study Xiaoqin Liu, 1 Esben Agerbo, 1,2,3 Katja G Ingstrup, 1 Katherine Musliner, 1,3

More information

Autism spectrum disorder in under 19s: recognition, referral and diagnosis

Autism spectrum disorder in under 19s: recognition, referral and diagnosis 1 National Institute for Health and Care Excellence Final Autism spectrum disorder in under 19s: recognition, referral and diagnosis [A] Evidence review for factors and neurodevelopmental disorders that

More information

Figure S1. Flowchart of sample included in the analysis.

Figure S1. Flowchart of sample included in the analysis. Figure S1. Flowchart of sample included in the analysis. 3098 mother/infant pairs with EMR records of well-child and specialty visits 418 cases with any ADHD diagnosis 94 cases with any ASD diagnosis while

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia

More information

Antidepressants. Professor Ian Jones May /WalesMentalHealth

Antidepressants. Professor Ian Jones May /WalesMentalHealth Antidepressants Professor Ian Jones May 2017 www.ncmh.info @ncmh_wales /WalesMentalHealth 029 2074 4392 info@ncmh.info We identified 19 740 pregnancies exposed to an antidepressant at some point during

More information

1. Family aggregation and long-term outcome of psychopathology in children and adolescents in the Danish Three Generation Study (3GS)

1. Family aggregation and long-term outcome of psychopathology in children and adolescents in the Danish Three Generation Study (3GS) Aalborg CAP research programme 2016 1. Family aggregation and long-term outcome of psychopathology in children and adolescents in the Danish Three Generation Study (3GS) Objectives: Study of the aggregation

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Gomes T, Redelmeier DA, Juurlink DN, et al. Opiod dose and risk of road trauma in Canada: a populationbased study. JAMA Intern Med. Published online January 14, 2013. doi:10.1001/2013.jamainternmed.733.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Ribe AR, Laursen TM, Charles M, et al. Long-term risk of dementia in persons with schizophrenia: a Danish population-based cohort study. JAMA Psychiatry. Published online October

More information

To clarify this issue, we have made the following changes to the Introduction and Discussion:

To clarify this issue, we have made the following changes to the Introduction and Discussion: Manuscript ID BMJ.2017.038618 "Risk of Neonatal Drug Withdrawal after Intrauterine Co-Exposure to Opioids and Psychotropic Medications: A Cohort Study" Please find below our replies to the comments made

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Mølgaard-Nielsen D, Hviid A. Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA. 2011;305(19):1996-2002. emethods. Birth defects and potential confounders

More information

efigure. Directed Acyclic Graph to Determine Whether Familial Factors Exist That Contribute to Both Eating Disorders and Suicide

efigure. Directed Acyclic Graph to Determine Whether Familial Factors Exist That Contribute to Both Eating Disorders and Suicide Supplementary Online Content Yao S, Kuja-Halkola R, Thornton LM, et al. Familial liability for eating s and suicide attempts: evidence from a population registry in Sweden. JAMA Psychiatry. Published online

More information

Nature Genetics: doi: /ng Supplementary Figure 1

Nature Genetics: doi: /ng Supplementary Figure 1 Supplementary Figure 1 Illustrative example of ptdt using height The expected value of a child s polygenic risk score (PRS) for a trait is the average of maternal and paternal PRS values. For example,

More information

Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder

Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder Hannah Sauer, PharmD PGY1 Pediatric Pharmacy Resident Mayo Clinic 2015 MFMER slide-1 Objectives

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Zusterzeel R, Selzman KA, Sanders WE, et al. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patientlevel data. Published online

More information

Parental age and autism: Population data from NJ

Parental age and autism: Population data from NJ Parental age and autism: Population data from NJ Introduction While the cause of autism is not known, current research suggests that a combination of genetic and environmental factors may be involved.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Rollman BL, Herbeck Belnap B, Abebe KZ, et al. Effectiveness of online collaborative care for treating mood and anxiety disorders in primary care: a randomized clinical trial.

More information

Dr Veenu Gupta MD MRCPsych Consultant, Child Psychiatrist Stockton on Tees, UK

Dr Veenu Gupta MD MRCPsych Consultant, Child Psychiatrist Stockton on Tees, UK Dr Veenu Gupta MD MRCPsych Consultant, Child Psychiatrist Stockton on Tees, UK Extremely Preterm-EP Very Preterm-VP Preterm-P Late Preterm-LP There is greater improvement of survival at extremely low

More information

6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.

6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related. Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders

More information

University of Bristol - Explore Bristol Research. Peer reviewed version. Link to published version (if available): /peds.

University of Bristol - Explore Bristol Research. Peer reviewed version. Link to published version (if available): /peds. Gustavson, K., Ystrom, E., Stoltenberg, C., Susser, E., Suren, P., Magnus, P.,... Reichborn-Kjennerud, T. (2017). Smoking in pregnancy and child ADHD. Pediatrics, 139(2), [e20162509]. DOI: 10.1542/peds.2016-2509

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Renoux C, Vahey S, Dell Aniello S, Boivin J-F. Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurol. Published

More information

Psychiatric problems common in siblings of people with autism

Psychiatric problems common in siblings of people with autism NEWS Psychiatric problems common in siblings of people with autism BY ANN GRISWOLD 23 JUNE 2016 Psychiatric conditions crop up more than twice as often in families that include a child with autism as in

More information

Hypomania spectrum disorder in adolescence: a 15-year follow-up of non-mood morbidity in adulthood

Hypomania spectrum disorder in adolescence: a 15-year follow-up of non-mood morbidity in adulthood Päären et al. BMC Psychiatry 2014, 14:9 RESEARCH ARTICLE Open Access Hypomania spectrum disorder in adolescence: a 15-year follow-up of non-mood morbidity in adulthood Aivar Päären 1*, Hannes Bohman 1,

More information

What can genetic studies tell us about ADHD? Dr Joanna Martin, Cardiff University

What can genetic studies tell us about ADHD? Dr Joanna Martin, Cardiff University What can genetic studies tell us about ADHD? Dr Joanna Martin, Cardiff University Outline of talk What do we know about causes of ADHD? Traditional family studies Modern molecular genetic studies How can

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Hudson JI, McElroy SL, Ferreira-Cornwell MC, Radewonuk J, Gasior M. Efficacy of lisdexamfetamine in adults with moderate to severe binge-eating disorder: a randomized clinical

More information

Page 1 of 7. Supplemental Analysis

Page 1 of 7. Supplemental Analysis Data Supplement for Birmaher et al., Longitudinal Trajectories and Associated Baseline Predictors in Youths With Bipolar Spectrum Disorders. Am J Psychiatry (doi: 10.1176/appi.ajp.2014.13121577) Supplemental

More information

Supplementary Online Content 2

Supplementary Online Content 2 Supplementary Online Content 2 Bieleninik Ł, Geretsegger M, Mössler K, et al; TIME-A Study Team. Effects of improvisational music therapy vs enhanced standard care on symptom severity among children with

More information

IV. Additional information regarding diffusion imaging acquisition procedure

IV. Additional information regarding diffusion imaging acquisition procedure Data Supplement for Ameis et al., A Diffusion Tensor Imaging Study in Children with ADHD, ASD, OCD and Matched Controls: Distinct and Non-distinct White Matter Disruption and Dimensional Brain-Behavior

More information

Table 1 Results of the 12-item General Health Questionnaire among caregivers who were or were not evacuated Not evacuated (N=46)

Table 1 Results of the 12-item General Health Questionnaire among caregivers who were or were not evacuated Not evacuated (N=46) Table 1 Results of the 12-item General Health Questionnaire among caregivers who were or were not evacuated Not evacuated (N=46) Evacuated (N=46) Item N % N % 2a p Unable to concentrate 4 4 20 22 14.4

More information

Nature Genetics: doi: /ng Supplementary Figure 1

Nature Genetics: doi: /ng Supplementary Figure 1 Supplementary Figure 1 Relationship of the Icelandic psychosis family to five individuals (X1 X5) who carry the haplotype harboring RBM12 c.2377g>t but not RBM12 c.2377g>t. An asterisk marks whole-genome-sequenced

More information

ABSTRACT Objective To assess the potential association between prenatal

ABSTRACT Objective To assess the potential association between prenatal open access Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study Kenneth K C Man, 1,2,3,4 Esther W Chan, 1 Patrick Ip, 2 David Coghill,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Henson KE, Brock R, Charnock J, Wickramasinghe B, Will O, Pitman A. Risk of suicide after cancer diagnosis in England. JAMA Psychiatry. Published online November 21, 2018.

More information

Mental and physical health in adult autism. Dr Conor Davidson Hazel Griffiths (carer)

Mental and physical health in adult autism. Dr Conor Davidson Hazel Griffiths (carer) Mental and physical health in adult autism Dr Conor Davidson Hazel Griffiths (carer) Plan for today What is autism and why is it important we know about it? Key features of autism Autism and mental health

More information

Supplementary appendix: Oral polio vaccination and hospital admissions with non-polio infections in Denmark: Nationwide retrospective cohort study

Supplementary appendix: Oral polio vaccination and hospital admissions with non-polio infections in Denmark: Nationwide retrospective cohort study Supplementary appendix: Oral polio vaccination and hospital admissions with non-polio infections in Denmark: Nationwide retrospective cohort study Signe Sørup, Lone G. Stensballe, Tyra G. Krause, Peter

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Ebbing M, Bønaa KH, Nygård O, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B 1. JAMA. 9;3(19):119-1. etable 1. Circulating Levels of B

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Sun LS, Li G, Miller TLK, et al. Association between a single general anesthesia exposure before age 36 months and neurocognitive outcomes in later childhood. JAMA. doi:10.1001/jama.2016.6967

More information

Advocating for people with mental health needs and developmental disability GLOSSARY

Advocating for people with mental health needs and developmental disability GLOSSARY Advocating for people with mental health needs and developmental disability GLOSSARY Accrued deficits: The delays or lack of development in emotional, social, academic, or behavioral skills that a child

More information

SUMMARY AND DISCUSSION

SUMMARY AND DISCUSSION Risk factors for the development and outcome of childhood psychopathology SUMMARY AND DISCUSSION Chapter 147 In this chapter I present a summary of the results of the studies described in this thesis followed

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553-1559. eequation. Applying the

More information

PREGNANCY SMOKING AND ANTI-SOCIAL BEHAVIOUR. In the last decade there has been increasing. interest and research into the associations between

PREGNANCY SMOKING AND ANTI-SOCIAL BEHAVIOUR. In the last decade there has been increasing. interest and research into the associations between PREGNANCY SMOKING AND ANTI-SOCIAL BEHAVIOUR In the last decade there has been increasing interest and research into the associations between pregnancy smoking and antisocial behaviours. This overview looks

More information

NIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2014 June 24.

NIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2014 June 24. NIH Public Access Author Manuscript Published in final edited form as: JAMA Intern Med. 2013 June 24; 173(12): 1150 1151. doi:10.1001/jamainternmed.2013.910. SSRI Use, Depression and Long-Term Outcomes

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Anagnostou E, Aman MG, Handen BL, et al. Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autistic spectrum disorder:

More information

GeMS Young Adult Self-Report Questionnaire

GeMS Young Adult Self-Report Questionnaire Patient Name: D.O.B: MRN: GeMS Young Adult Self-Report Questionnaire This form will help us learn about you prior to your appointment in GeMS. It asks about your gender identity experience, mental health,

More information

History Form for Adult Client

History Form for Adult Client History Form for Adult Client Referral Date: Who referred you to our office (please circle one)? Self Other, please specify: Reason for Referral: Require a Diagnostic Evaluation for Autism Spectrum Disorder

More information

Self-reported data on medicine use in the Norwegian Mother and Child cohort study compared to data from the Norwegian Prescription Database

Self-reported data on medicine use in the Norwegian Mother and Child cohort study compared to data from the Norwegian Prescription Database Norsk Epidemiologi 2014; 24 (1-2): 209-216 209 Self-reported data on medicine use in the Norwegian Mother and Child cohort study compared to data from the Norwegian Prescription Database Svetlana Skurtveit

More information

Asperger s Syndrome. severe difficulties interacting socially (Gillberg 2002). He named this difficulty

Asperger s Syndrome. severe difficulties interacting socially (Gillberg 2002). He named this difficulty Julie Burton 7.16.2012 ED 243 Paper Asperger s Syndrome History In 1944 an Austrian pediatrician named Hans Asperger wrote an article about a group of school- aged boys when he discovered that some of

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group. Effect of oral insulin on prevention of diabetes in relatives of patients with type 1 diabetes:

More information

SANDSTONE PSYCHOLOGICAL PRACTICE

SANDSTONE PSYCHOLOGICAL PRACTICE SANDSTONE PSYCHOLOGICAL PRACTICE Christina L. Aranda, Ph.D. & Janell M. Mihelic, Ph.D. CONTACT INFORMATION New Client Questionnaire Name: Date: Date of Birth: Age: _ Address: Preferred Phone Number: Type:

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Dodick DW, Silberstein SD, Bigal ME, et al. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial. JAMA. doi:10.1001/jama.2018.4853

More information

Use of Selective Serotonin Reuptake Inhibitors during Pregnancy and Risk of Autism

Use of Selective Serotonin Reuptake Inhibitors during Pregnancy and Risk of Autism The new england journal of medicine original article Use of Selective Serotonin Reuptake Inhibitors during Pregnancy and Risk of Autism Anders Hviid, Dr.Med.Sci., Mads Melbye, M.D., Dr.Med.Sci., and Björn

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Daly EJ, Singh JB, Fedgchin M, et al. Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized

More information

When the Bough Breaks

When the Bough Breaks Avoiding Crisis and the Loss of Life by Recognizing and Treating Angela Burling RN MSN Chris Raines MSN RN APRN-BC When the Bough Breaks Angela s Story Raines and Burling 1 A rare but devastatingcondition,

More information

Prenatal and Post Partum Depression is Not Just a Mood. This is Serious Stuff.

Prenatal and Post Partum Depression is Not Just a Mood. This is Serious Stuff. Prenatal and Post Partum Depression is Not Just a Mood. This is Serious Stuff. Deborah McMahan, MD Health Commissioner Prenatal and Infant Care Network November 28, 2016 Agenda Prevalence of mental illness

More information

ESP 755A SUMMER Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Autosomal recessive disorders

ESP 755A SUMMER Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Autosomal recessive disorders ESP 755A SUMMER 2017 Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Autosomal recessive disorders a. affect only males c. are caused when the abnormal

More information

Maternal age at childbirth and risk for ADHD in offspring: a population-based cohort study

Maternal age at childbirth and risk for ADHD in offspring: a population-based cohort study International Journal of Epidemiology, 2014, 1815 1824 doi: 10.1093/ije/dyu204 Advance Access Publication Date: 29 October 2014 Original article Original article Maternal age at childbirth and risk for

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Hafeman DM, Merranko J, Goldstein TR, et al. Assessment of a person-level risk calculator to predict new-onset bipolar spectrum disorder in youth at familial risk. JAMA Psychiatry.

More information

Developmental-Behavioral Pediatrics Questionnaire for New Patients

Developmental-Behavioral Pediatrics Questionnaire for New Patients Developmental-Behavioral Pediatrics Questionnaire for New Patients Date: Name of person completing questionnaire: Relationship to child: Email: IDENTIFYING INFORMATION: Information Child Name Child Birthdate

More information

PRESCRIBING GUIDELINES

PRESCRIBING GUIDELINES The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors

More information

Information for Providers on Antidepressants during Pregnancy and Breastfeeding January 2018

Information for Providers on Antidepressants during Pregnancy and Breastfeeding January 2018 Antidepressants Risks in Pregnancy Safety Data: No randomized control trials. Safety data derived largely from cohort studies, registry data, and prescription monitoring registries. Older studies suggested

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Irish AB, Viecelli AK, Hawley CM, et al; for the Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

More information

THE FIRST NINE MONTHS AND CHILDHOOD OBESITY. Deborah A Lawlor MRC Integrative Epidemiology Unit

THE FIRST NINE MONTHS AND CHILDHOOD OBESITY. Deborah A Lawlor MRC Integrative Epidemiology Unit THE FIRST NINE MONTHS AND CHILDHOOD OBESITY Deborah A Lawlor MRC Integrative Epidemiology Unit d.a.lawlor@bristol.ac.uk Sample size (N of children)

More information

This is an author produced version of a paper not yet published by a journal. This version is the preprint (not peerreviewed)

This is an author produced version of a paper not yet published by a journal. This version is the preprint (not peerreviewed) This is an author produced version of a paper not yet published by a journal. This version is the preprint (not peerreviewed) and does not include the final publisher proofcorrections or journal pagination.

More information

The Familial Risk of Autism

The Familial Risk of Autism Research Original Investigation The Familial Risk of Autism Sven Sandin, MSc; Paul Lichtenstein, PhD; Ralf Kuja-Halkola, MSc; Henrik Larsson, PhD; Christina M. Hultman, PhD; Abraham Reichenberg, PhD IMPORTANCE

More information

7 th Annual ECMH Conference 2016 Alison Reminick, MD

7 th Annual ECMH Conference 2016 Alison Reminick, MD Objectives MATERNAL DEPRESSION Director of Women s Reproductive Mental Health University California, San Diego Describe the effects of maternal depression on fetal and neonatal health Describe normal changes

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Patorno E, Huybrechts KF, Bateman BT, et al. Lithium use in

More information

PHARMACOLOGICAL THERAPY OF AUTISM SPECTRUM DISORDERS IN THE CLINICAL PRACTICE

PHARMACOLOGICAL THERAPY OF AUTISM SPECTRUM DISORDERS IN THE CLINICAL PRACTICE ANTON et al. ORIGINAL PAPERS PHARMACOLOGICAL THERAPY OF AUTISM SPECTRUM DISORDERS IN THE CLINICAL PRACTICE Andra ISAC 2, Magdalena KWASIUK 1, Roxana ȘIPOȘ 1, Ioana MICLUȚIA 1, Viorel LUPU 1, Elena PREDESCU

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Malik S, Zhao Y, Budoff M, et al. Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the Multi-Ethnic

More information

COMORBIDITY PREVALENCE AND TREATMENT OUTCOME IN CHILDREN AND ADOLESCENTS WITH ADHD

COMORBIDITY PREVALENCE AND TREATMENT OUTCOME IN CHILDREN AND ADOLESCENTS WITH ADHD COMORBIDITY PREVALENCE AND TREATMENT OUTCOME IN CHILDREN AND ADOLESCENTS WITH ADHD Tine Houmann Senior Consultant Child and Adolescent Mental Health Center, Mental Health Services Capital Region of Denmark

More information

Apgar score and risk of autism

Apgar score and risk of autism European Journal of Epidemiology https://doi.org/10.1007/s10654-018-0445-1 (0456789().,-volV)(0456789().,-volV) PERINATAL EPIDEMIOLOGY Apgar score and risk of autism Amirhossein Modabbernia 1,2 Sven Sandin

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Choudhry NK, Krumme AA, Ercole PM, et al. Effect of reminder devices on medication adherence: the REMIND randomized clinical trial. JAMA Int Med. Published online February

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL efigures efigure: Standardised differences between TNF-α inhibitor users and non-users before and after matching on fixed factors and propensity scores. etables etable 1: All diagnoses

More information

Unit 1. Behavioral Health Course. ICD-10-CM Specialized Coding Training. For Local Health Departments and Rural Health

Unit 1. Behavioral Health Course. ICD-10-CM Specialized Coding Training. For Local Health Departments and Rural Health ICD-10-CM Specialized Coding Training http://publichealth.nc.gov/lhd/icd10/training.htm Behavioral Health Course For Local Health Departments and Rural Health Unit 1 1 Behavioral Health Training Objectives

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Schmidt B, Whyte RK, Asztalos EV, et al; for the Canadian Oxygen Trial (COT) Group. Effects of targeting higher vs lower arterial oxygen saturations on death or disability

More information

11/12/2017. How effective are treatments of psychiatric disorders in children and adolescents?

11/12/2017. How effective are treatments of psychiatric disorders in children and adolescents? How effective are treatments of psychiatric disorders in children and adolescents? Benedetto Vitiello, M.D. Pavia, November 22, 2017 1 Disclosure Benedetto Vitiello, M.D. Professor of Child and Adolescent

More information

Prenatal risk factors for Tourette Syndrome: a systematic review

Prenatal risk factors for Tourette Syndrome: a systematic review Chao et al. BMC Pregnancy and Childbirth 2014, 14:53 RESEARCH ARTICLE Prenatal risk factors for Tourette Syndrome: a systematic review Ting-Kuang Chao 1, Jing Hu 2 and Tamara Pringsheim 2,3* Open Access

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Blumenthal SR, Castro VM, Clements CC, et al. An electronic health records study of long-term weight gain following antidepressent use. JAMA Psychiatry. Published online June

More information

Anesthetic Neurotoxicity in Children: Review and Update?

Anesthetic Neurotoxicity in Children: Review and Update? Anesthetic Neurotoxicity in Children: Review and Update? Randall Flick MD, MPH Associate Professor of Anesthesiology & Pediatrics Chair, Division of Pediatric Anesthesiology Medical Director, Mayo Eugenio

More information

Website Updates: February, 2016 Kevin T. Blake, Ph.D., P.L.C.

Website Updates: February, 2016 Kevin T. Blake, Ph.D., P.L.C. Website Updates: February, 2016 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Kevin T. Blake, Ph.D., P.L.C. 1 Barkley On How AD/HD Medications Work Stimulants: Work on dopamine Stimulants work on executive

More information

Parental Rheumatoid Arthritis and Autism Spectrum Disorders in Offspring: A Danish Nationwide Cohort Study

Parental Rheumatoid Arthritis and Autism Spectrum Disorders in Offspring: A Danish Nationwide Cohort Study NEW RESEARCH Parental Rheumatoid Arthritis and Autism Spectrum Disorders in Offspring: A Danish Nationwide Cohort Study Ane Lilleøre Rom, PhD, Chun Sen Wu, PhD, Jørn Olsen, PhD, Damini Jawaheer, PhD, Merete

More information

Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care

Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care CLINICAL ASSESSMENT AND DIAGNOSIS (ADULTS) Obsessive-Compulsive Disorder (OCD) is categorized by recurrent obsessions,

More information

Mental Health Series for Perinatal Prescribers. Perinatal Depression

Mental Health Series for Perinatal Prescribers. Perinatal Depression Mental Health Series for Perinatal Prescribers Perinatal Depression Perinatal Depression Timing of symptoms Maternal depression is present before or during pregnancy at least 60% of the time DSM-5 and

More information

2017 American Medical Association. All rights reserved.

2017 American Medical Association. All rights reserved. Supplementary Online Content Borocas DA, Alvarez J, Resnick MJ, et al. Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3

More information

Introduction. Laura A. Schieve 1 Christine Fountain. Dmitry M. Kissin 3 Denise J. Jamieson

Introduction. Laura A. Schieve 1 Christine Fountain. Dmitry M. Kissin 3 Denise J. Jamieson J Autism Dev Disord (2015) 45:2991 3003 DOI 10.1007/s10803-015-2462-1 ORIGINAL PAPER Does Autism Diagnosis Age or Symptom Severity Differ Among Children According to Whether Assisted Reproductive Technology

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Schnabel RB, Aspelund T, Li G, et al. Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med. 2010;170(21):1909-1917. eappendix.

More information

Dr Keith Ganasen Department of Psychiatry UCT

Dr Keith Ganasen Department of Psychiatry UCT Dr Keith Ganasen Department of Psychiatry UCT A. Significantly subaverage intellectual functioning: an IQ of approximately 70 or below on an individually administered IQ test B. Concurrent deficits or

More information

Pharmacy Prior Authorization GMH/SA and Non-Title 19/21 SMI Non-Formulary and Prior Authorization Guidelines

Pharmacy Prior Authorization GMH/SA and Non-Title 19/21 SMI Non-Formulary and Prior Authorization Guidelines Non-Formulary Behavioral Health Medications ADHD medications for children under The patient must have a diagnosis for which the requested medication is: o Approved based on FDA indication and limits; OR

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Jänne PA, van den Heuvel MM, Barlesi F, et al. Effect of selumetinib plus docetaxel compared with docetaxel alone and progression-free survival in patients with KRASmutant

More information

Supplementary Table 1. Basic sample characteristics FEP (n=51) ARMS (n=46) Controls (n=53) Test statistic. F=18.6, df=2

Supplementary Table 1. Basic sample characteristics FEP (n=51) ARMS (n=46) Controls (n=53) Test statistic. F=18.6, df=2 This supplementary material accompanies the article: Klippel, A., Myin-Germeys, I., Chavez-Baldini, U., Preacher, K. J., Kempton, M., Valmaggia, L., Calem, M., So, S., Beards, S., Hubbard, K., Gayer-Anderson,

More information

ORIGINAL ARTICLE. Family History of Psychiatric Illness as a Risk Factor for Schizoaffective Disorder

ORIGINAL ARTICLE. Family History of Psychiatric Illness as a Risk Factor for Schizoaffective Disorder ORIGINAL ARTICLE Family History of Psychiatric Illness as a Risk Factor for Schizoaffective Disorder A Danish Register-Based Cohort Study Thomas Munk Laursen, MSc; Rodrigo Labouriau, PhD; Rasmus W. Licht,

More information